PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 2010Future Microbiology216 citationsOpen Access

Human Papillomavirus: Gene Expression, Regulation and Prospects For Novel Diagnostic Methods and Antiviral Therapies

View Full Paper
SGSheila V. Graham

Key Points

Key points are not available for this paper at this time.

Abstract

Human papillomaviruses (HPVs) cause diseases ranging from benign warts to invasive tumors. A subset of these viruses termed 'high risk' infect the cervix where persistent infection can lead to cervical cancer. Although many HPV genomes have been sequenced, knowledge of virus gene expression and its regulation is still incomplete. This is due in part to the lack, until recently, of suitable systems for virus propagation in the laboratory. HPV gene expression is polycistronic initiating from multiple promoters. Gene regulation occurs at transcriptional, but particularly post-transcriptional levels, including RNA processing, nuclear export, mRNA stability and translation. A close association between the virus replication cycle and epithelial differentiation adds a further layer of complexity. Understanding HPV mRNA expression and its regulation in the different diseases associated with infection may lead to development of novel diagnostic approaches and will reveal key viral and cellular targets for development of novel antiviral therapies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sheila V. Graham (2010) studied this question.

synapsesocial.com/papers/6a61a5d4dcbd73a1130a7aa0https://doi.org/10.2217/fmb.10.107
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia1998 · 37 citations
  2. 2Papillomavirus Research: From Natural History to Vaccines and Beyond2006 · 138 citations
  3. 3RNAi‐based therapeutics–current status, challenges and prospects2009 · 286 citations
  4. 4Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers2007 · 35 citations
  5. 5The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels2000 · 60 citations